As filed with the Securities and Exchange Commission on December 30, 2025 Registration No. 333-290302 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 LYTUS TECHNOLOGIES HOLDINGS PTV. LTD. (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 7841 Not applicable (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number ...

Core Insights - Doximity, Inc. (NYSE: DOCS) operates an online platform service that has experienced significant growth in user engagement, particularly among medical prescribers [1] - The growth momentum is expected to continue, driven by the pharmaceutical marketing segment, which has been identified as a key area for expansion [1] Company Overview - Doximity provides a platform that connects healthcare professionals, enhancing communication and collaboration within the medical community [1] - The company has seen a notable increase in user engagement, indicating a strong demand for its services among medical prescribers [1] Industry Context - The pharmaceutical marketing segment is anticipated to be a major contributor to Doximity's ongoing growth, highlighting the intersection of technology and healthcare marketing [1]